No spam - just the good stuff

Subscribe to our newsletter

News

Economy

VitaDAO and GlycanAge explore longevity and DeSci in Abu Dhabi event

Longevity.Technology announces entry into Asia Pacific markets

SenoClock Gold: Bringing the antiaging paradigm to work

Deep Longevity's aging clock platform is aiming to elevate employee health and wellbeing with AI-powered insights.

Ending Aging Forum 2023

Longevity on the rise

Treat the mind, treat the body: Addressing a fundamental gap in acute disease management

Wonderland Conference expands into longevity and mental health

Research into Blue Zones longevity enriches Florida youth – and Netflix

Brigham researchers offer cohesive framework for evaluating biomarkers of aging

Alexandra Hospital opens world’s first Healthy Longevity Clinic in a public hospital

‘Healthy Aging and Longevity Forum’ to take place at HKBIO2023 International Convention

1.25 million thank yous

TimePie Longevity Forum: More than 40 global longevity speakers to meet in China this December

Edward Norton joins longevity movie’s stellar line-up

Ending Age-Related Diseases conference looks to future of longevity

Swiss longevity company Epiterna exits stealth to tackle aging

Longevity investing: Navigating hype cycles to preserve reputable technologies

Dunedin Study receives £1.4m award to explore midlife aging

Impetus announces $10 million for aging science research grants

Advancing human healthspan: Longevity Summit Dublin’s agenda unveiled

SRF experiment.com campaign sets sights on mitochondrial DNA

Time to shelve the concept of death?

FDA approves novel Alzheimer’s treatment

VitaDAO launches VITA-FAST tokens building on 2000% initial oversubscription

SENS Research Foundation cuts the ribbon on cutting-edge longevity facilities

More than 30 prominent longevity speakers to attend investors-only conference

Samsara brings eminent neurologist on board to accelerate ALS/MND treatment development

RAADfest 2023: It’s time to meet your future face-to-face

Rapamycin: mTOR, autophagy and treating mTOR syndrome

Navigate the emerging field of longevity

It’s a brave new world – but longevity needs to stay in the realm of the credible

Senescence in a dish: SENS launches first experiment.com campaign

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS

The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.